In a number of articles published in JAMA Internal Medicine,1,2,3,4,5,6 conflict of interest disclosures were not reported completely by Vinay Prasad, MD, MPH. Dr Prasad has written a letter to the journal,7 explaining this inconsistent reporting of potential conflict of interest disclosures. All articles have been corrected online.
References
- 1.Gerrity MS, Prasad V, Obley AJ. Concerns about the approval of nusinersen sodium by the US Food and Drug Administration. JAMA Intern Med. 2018;178(6):743-744. doi: 10.1001/jamainternmed.2018.0869 [DOI] [PubMed] [Google Scholar]
- 2.Prasad V, Mailankody S. Assessing pharmaceutical research and development costs—reply. JAMA Intern Med. 2018;178(4):588-589. doi: 10.1001/jamainternmed.2017.8737 [DOI] [PubMed] [Google Scholar]
- 3.Prasad V. Unanticipated Outcomes: A Medical Memoir—a book review. JAMA Intern Med. 2018;178(1):11-12. doi: 10.1001/jamainternmed.2017.6573 [DOI] [Google Scholar]
- 4.Prasad V, Mailankody S. Research and development spending to bring a single cancer drug to market and revenues after approval. JAMA Intern Med. 2017;177(11):1569-1575. doi: 10.1001/jamainternmed.2017.3601 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Friedberg MW, Gellad WF, Prasad V. Limitations concerning the association of physician sex and patient outcomes. JAMA Intern Med. 2017;177(7):1058. doi: 10.1001/jamainternmed.2017.2142 [DOI] [PubMed] [Google Scholar]
- 6.Tao DL, Boothby A, McLouth J, Prasad V. Financial conflicts of interest among hematologist-oncologists on Twitter. JAMA Intern Med. 2017;177(3):425-427. doi: 10.1001/jamainternmed.2016.8467 [DOI] [PubMed] [Google Scholar]
- 7.Prasad V. Inconsistent reporting of potential conflicts of interest [published online August 13, 2018]. JAMA Intern Med. doi: 10.1001/jamainternmed.2018.3695 [DOI] [PubMed] [Google Scholar]
